Company Filing History:
1 out of 612 
1 out of 1 
1 out of 1 Years Active: 2022-2025
Title: Linqi Zhang: Innovator in Pharmaceutical Research
Introduction
Linqi Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the fight against viral infections. With a total of 2 patents, his work focuses on innovative solutions to combat SARS-CoV-2.
Latest Patents
Linqi Zhang's latest patents include groundbreaking research on the use of Ovatodiolide against SARS-CoV-2. This compound, known as Formula I, is recognized for its safety and effectiveness in pharmaceutical compositions aimed at inhibiting SARS-CoV-2. The composition includes a safe and effective amount of Ovatodiolide or its pharmaceutically acceptable salts, combined with a suitable carrier, showcasing great potential for treating COVID-19. Another notable patent involves modified anti-SARS-CoV-2 antibodies or antigen-binding fragments that possess extended half-life and optimized immune activities. This patent also details pharmaceutical compositions and methods for treating or preventing diseases related to SARS-CoV-2 infections.
Career Highlights
Linqi Zhang has worked at Peking University, where he has contributed to various research initiatives. His expertise in pharmaceutical sciences has positioned him as a key figure in the development of treatments for viral infections.
Collaborations
Linqi Zhang has collaborated with notable colleagues, including Qi Zhang and Zheng Zhang, enhancing the scope and impact of his research efforts.
Conclusion
Linqi Zhang's innovative work in pharmaceutical research, particularly against SARS-CoV-2, highlights his commitment to advancing medical science. His patents reflect a dedication to finding effective treatments for pressing health challenges.